Pfizer’s COVID Vaccine Shows Promising Results
America is desperate for some optimism in the fight against COVID-19, and on Monday Pfizer delivered. The pharmaceutical company’s initial COVID vaccine, developed in partnership with the BioNTech, released findings that the vaccine was 90% effective in early tests. Though more testing is needed, the news is a bright spot, and the science community is celebrating the milestone. Dr. Anthony Fauci, the US’s Infectious Disease Expert, said the news was “just extraordinary,” according to AP News.
With a potential vaccine on the horizon, and still more companies with their own vaccines in late stage trials, the future seems bright. But MarkeStcale hosts Daniel Litwin and Tyler Kern pose some critical questions about what this means for business in America. Tyler considers what this will mean for the economy as businesses see the possibility of bouncing back on the horizon, and Daniel questions, with Pfizer’s vaccine being entirely self-funded, the ethics surrounding a successful vaccine from a privately-funded pharmaceutical giant.
KEY POINTS:
- Pfizer’s early vaccine findings show promise and boost the economy.
- Pfizer’s privately funded vaccine could be in production by the end of 2020.
- Dr. Fauci praises the findings, but more studies are needed before filing for FDA approval.
For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.
Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale
